News - Prostate Cancer
BATON ROUGE, La., June 4, 2012 /PRNewswire/ -- Esperance Pharmaceuticals presented its Phase 1 study of EP-100, a novel targeted membrane?disrupting peptide (tMDP) in advanced solid tumors
NEW YORK, June 4, 2012 /PRNewswire/ -- Exosome Diagnostics today announced it has reached agreement with Life Technologies to use the Applied Biosystems® (ABI) 7500 Fast Dx
BOTHELL, Wash. and VANCOUVER, British Columbia, June 4, 2012 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
Phase 3 Results Show Significant Improvement in Radiographic Progression-Free Survival and a Trend for Increased Overall Survival in Patients Receiving ZYTIGA® Plus Prednisone TORONTO,
LOS ANGELES, June 4, 2012 /PRNewswire/ -- On The Line, a national prostate cancer awareness campaign, today announced the nominations for the first annual 2012 "Big Daddy Awards" -- from Brad
